GlassScriptPhysician profile
Marisa Lopez
NPI 1770538605
$1,400.76
in general payments reported to CMS, 2019-2025
15 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $789 · 2020: $295 · 2021: $164 · 2022: $28.00 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $124.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $254.85 | 2019-2022 | |
| Ucb, INC. | $248.64 | 2019-2025 | Fintepla |
| Aquestive Therapeutics, INC. | $165.58 | 2019-2020 | |
| Stryker Corporation | $149.50 | 2019 | |
| Emd Serono, INC. | $133.47 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $125.16 | 2019-2020 | |
| Lilly USA, LLC | $82.75 | 2019-2021 | |
| Greenwich Biosciences, INC. | $52.91 | 2019-2020 | |
| Tanabe Pharma America, INC. | $42.92 | 2019-2020 | |
| Eisai INC. | $36.86 | 2019 | |
| Allergan, INC. | $26.82 | 2020 | |
| Akcea Therapeutics, INC. | $23.92 | 2020 | |
| Portola Pharmaceuticals, LLC | $20.61 | 2019 | |
| Csl Behring | $19.30 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marisa Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.